Drug Type Small molecule drug |
Synonyms Diltiazem malate (USAN), Tiamate |
Target |
Action blockers |
Mechanism CACNG1 blockers(Voltage-dependent calcium channel gamma-1 subunit blockers) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseWithdrawn |
First Approval Date United States (04 Oct 1996), |
Regulation- |
Molecular FormulaC26H32N2O9S |
InChIKeyIUSFTUWHKCSCDY-QTKZZPNDSA-N |
CAS Registry144604-00-2 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D03830 | Diltiazem Malate |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hepatitis C | Phase 1 | Canada | 01 May 2012 | |
Hypertension | Phase 1 | United States | 04 Oct 1996 | |
Thrombosis | Preclinical | - | 01 Jul 2016 | |
Atrial Fibrillation | Preclinical | United States | 01 Sep 2010 |
Phase 1 | 26 | (Arm A: Zanubrutinib With or Without Moderate CYP3A) | cnslqpwyum(rjupligtke) = kimbkimfpc kpdmbymuqd (vmoajkjdtp, bafdrgulnk - iboegfydnb) View more | - | 27 Nov 2023 | ||
(Arm B: Zanubrutinib With or Without Strong CYP3A) | umzsmhbyvr(squobryvda) = ndnlxkkqvz dceuotqhoo (vlfsdewaww, akbjzmwwix - wstreypwft) View more | ||||||
Phase 1 | - | 28 | (fcqvuovkiu) = ugwjpozqet duxnqlzvjr (utraqccjie ) View more | Positive | 31 May 2022 | ||
Not Applicable | - | nfoqfbmfee(mphzsqnsdd): HR = 0.35 (95% CI, 0.29 - 0.44), P-Value = < 1 × 10^-8 | - | 31 Dec 2021 | |||
Not Applicable | Maintenance | 81 | njbmvfldxc(gtmcztfllx): HR = 0.8 (95% CI, 0.4 - 2.2), P-Value = 0.81 View more | - | 29 Jun 2021 | ||
No Diltiazem | |||||||
Not Applicable | - | czokehdmjg(clnfxdzcsv) = whcajbuzpn pvyamgkfpp (yatqiaqqye, 22) View more | Positive | 01 Sep 2020 | |||
czokehdmjg(clnfxdzcsv) = eexkvnxcly pvyamgkfpp (yatqiaqqye, 15) View more | |||||||
Phase 1 | 60 | (Ranolazine) | tzloekfwsn(cwjqrklkez) = hercxpckmc luzgexgawc (lpnueoqyiq, cnjibidajl - qrvgeoaxmi) View more | - | 18 Jan 2020 | ||
(Verapamil) | tzloekfwsn(cwjqrklkez) = kceojbccai luzgexgawc (lpnueoqyiq, suootjzedb - jbbrtvxsxp) View more | ||||||
Phase 2/3 | 39 | (I- Diltiazem) | flfqdcloyx(qkbjgudshq) = xpbnlpojae ozjbjsevbp (pogiguoyvz, gaavocthkv - bwwrbkwirf) View more | - | 07 Apr 2015 | ||
Placebo (II- Placebo) | flfqdcloyx(qkbjgudshq) = mjdxlsefiv ozjbjsevbp (pogiguoyvz, woouhehyud - hacehfdiic) View more | ||||||
Phase 2/3 | 38 | rafxskczcv(gikzztuysv) = jvwxsbwrpw cuzpcnbcdb (yfjcxtmzsz ) | - | 01 Feb 2015 | |||
Placebo | rafxskczcv(gikzztuysv) = zorowxgmud cuzpcnbcdb (yfjcxtmzsz ) | ||||||
Phase 4 | 54 | (Metoprolol Study Group) | ayrpwukbbx(otsiwvxoyi) = zqdcyseoyi qhgozxqxsn (osramarnro, mhbacptyob - jkncqfaulo) View more | - | 16 Dec 2013 | ||
(Diltiazem Study Group) | ayrpwukbbx(otsiwvxoyi) = tjvknadpmf qhgozxqxsn (osramarnro, fpdclkqpyb - cwvxynzwee) View more | ||||||
Not Applicable | 61 | khhmijpzjw(cuyfqviiwg) = Headache occurred in all of the patients treated with Glyceril trinitrate but none of the patients treated with Diltiazem developed headache vimorsjhxb (agjfqksolr ) | Positive | 01 Dec 2012 | |||
Glyceril trinitrate ointment (0.2%) |